Hydrogenology
Hydrogenology editorial study record

Hydrogen-rich saline promotes motor functional recovery following peripheral nerve autografting in rats

Zhang YG et al. · Exp Ther Med. 2015;10(2):727–732.

PreclinicalOther formsPublished 2015
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Randomized two-group rat sciatic-nerve autograft experiment

Research topic

Other neurological conditions

Administration classification

Other forms

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Female Sprague-Dawley rats after reversal autografting of a 10-mm sciatic-nerve segment

Sample

60 rats, with n=10/group at each of the 4-, 8- and 12-week behavioral time points and smaller assay subsets

Duration

Daily treatment with assessments at 4, 8 and 12 weeks

Intervention

Hydrogen-rich saline 5 mL/kg intraperitoneally every day

Hydrogen form

H₂ dissolved in saline — H₂ only, not Brown’s gas and not inhalation.

H₂ specification

Purified H₂ dissolved in saline for four hours at 0.4 MPa; the final dissolved-H₂ concentration was not reported.

H₂ flow

Not applicable — intraperitoneal saline, not gas inhalation; preparation flow was not reported.

O₂ delivered with H₂

No O₂ was co-delivered as part of the H₂ intervention.

Comparator

Equal-volume normal saline daily

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Sciatic functional index, nerve conduction, compound muscle action potentials, retrograde tracing, axon and myelin morphology and gastrocnemius atrophy

Reported result

The article reports higher regenerated-neuron and myelinated-axon counts, improved electrophysiology and sciatic functional index, and less target-muscle atrophy with H₂-rich saline.

Results-extraction completeness

Allocation, preparation, dose, schedule and principal outcomes checked in the open-access full text.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Preclinical autograft model with repeated measures and assay-specific subsamples; final H₂ concentration was not reported and no human participants were studied.

Applies directly to

Peripheral-nerve autografting in rats, not clinical nerve repair.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 26622383 · DOI: 10.3892/etm.2015.2518

Publisher access

Open-access full text is available through PMC and the publisher.

Extraction basis

Open-access PMC article and PubMed record; no retraction or expression of concern was shown in the checked records on 7 August 2026.

Record revision

2026-08-10